Agenda - Research & Education Day
20th ANNUAL ONCOLOGY RESEARCH & EDUCATION DAY
Lamplighter Inn, Best Western - Crystal Ballroom, Regency Room, Chelsea Room & Atrium
591 Wellington Road, London
Thursday June 13, 2023 - 8:30AM to 5:30PM
AGENDA
Overall Learning Objectives:
By the end of this program, participants will be able to:
1.To review contributions from different oncology disciplines, including medical oncology, radiation oncology, surgery, and medical biophysics, to a comprehensive cancer treatment approach; 2.Discuss and assess cutting-edge research in oncology, including novel methodologies for studying cancer at the cellular level and the implications for treatment resistance and patient care; 3.Appraise research findings and demonstrate how collaboration bridge clinical and basic science research in oncology.
| 7:45 - 9:00 | REGISTRATION AND OPENING REMARKS Atrium & Crystal Ballroom |
| 7:45 | Registration and Breakfast Please register and enjoy a light breakfast while networking with colleagues. |
| 8:30 | Welcome and Opening Remarks Vanessa Dumeaux PhD. and Ana Lohmann MD. PhD. - Conference Co-Chairs Michael Ott MD. FRCSC. - Chair/Chief Department of Oncology Kirk Baines - Philanthropist & Founder, Baines Centre for Translational Cancer Research |
| 9:00 - 10:10 | MORNING PRESENTATIONS Oncology Talks AND Oral Presentations Crystal Ballroom |
| 9:00 |
Experimental Oncology: Translating Science into Survival. - Division of Experimental Oncology - Saman Maleki PhD. Learning Objectives: 1. To describe how to transform immune cold tumors to immune hot via induction of DNA repair damage in tumor cells; 2. The describe the role of gut microbiome in anti-tumor immune response; 3. To describe how modifying the gut microbiome to increase the effectiveness of immunotherapy in patients. |
| 9:15 |
Is Anthracycline Chemotherapy Essential in the Treatment of Women with Breast Cancer? - Division of Medical Oncology - Danilo Giffoni MD. FRCPC. Learning Objectives: 1. Compare efficacy between anthracycline vs. non-anthracycline chemotherapy in early breast cancer; 2. Introduce treatment strategies for high-risk breast cancer; 3. Present cardiotoxicity risks induced by anthracycline |
| 9:30 | Oral Presentation 1 - Exploring the Role of Gut Microbiota on Immunologically Active Neuroblastoma Tumours - Hasti Gholami, MSc. Candidate |
| 9:40 | Oral Presentation 2 - Mice deficient in RanBP9 and p53 display increased tumourigenesis – Brianna Gonga-Cave, PhD Candidate |
| 9:50 | Oral Presentation 3 - Body Composition and Melanoma Outcomes in Patients on Immunotherapy or Targeted Therapy - an analysis from Canadian Melanoma Research Network - Sanji Ali, MO PGY5 |
| 10:00 | Oral Presentation 4 - Exploring the mutational landscape of pure ductal carcinoma in situ and its association with disease progression and response to radiotherapy - Noor Rizvi, MSc. Candidate |
| 10:10 - 11:45 | MORNING POSTER AND NETWORKING SESSION (Odd Numbers) Regency Conference Room AND Chelsea Meeting Room & Atrium |
| 10:10 | Poster Viewing and Judging (Odd Numbers) Please enjoy refreshments and a light snack while viewing the scientific poster presentations. |
| 11:45 - 12:45 | KEYNOTE LECTURE Co-Chairs: Vanessa Dumeaux and Ana Lohmann Crystal Ballroom |
|
Dissecting Tissue Genomes at Single-Cell Resolution Charles Gawad, MD. PhD.
Associate Professor, Pediatrics (Hematology/Oncology),
Faculty Fellow, Sarafan ChEM-H
Member, Stanford Cancer Institute, Stanford University, California;
Pediatric Hematology-Oncologist, Stanford Medicine Children's Health, California
Objectives:Define somatic mutation and explain how those genetic changes can contribute to diseases; Describe the tools used for single-cell sequencing and the unique information obtained from this approach compared to standard tissue-level sequencing; Define single-cell multiomics and discuss the insights into cancer biology that can be gained by studying the genome and transcriptome of the same cancer cell. |
|
| 12:45 - 1:45 | LUNCH Crystal Ballroom & Atrium |
| 1:45 - 3:10 | AFTERNOON PRESENTATIONS Oncology Talks AND Oral Presentations Crystal Ballroom |
| 1:45 |
Introducing a New Paradigm with Real-Time Adaptive Radiotherapy in London. Medical Biophysics - Jason Vickress PhD. MCCPM. Learning Objectives: Define Adaptive Radiotherapy in the current clinical context; 2. Examine new technologies enabling Real-Time Adaptive Radiotherapy in London; 3. Formulate future research projects for Real-Time Adaptive Radiotherapy. |
| 2:00 |
Adapting to Changing Ideals and Evolving Essentials in Radiation Oncology. Division of Radiation Oncology - Joelle Helou MD. FRCPC. Learning Objectives: 1. To review recent paradigm changes in metastatic cancer; 2. To integrate advanced technology in the changing landscape of systemic treatments and precision medicine; 3. To integrate patient values and preferences in our decision-making. |
| 2:15 |
Modern Approaches in Translational Breast Cancer Research. Learning Objectives: 1. To provide an overview describing some cutting-edge methodologies in translational breast cancer research; 2. To describe how these technologies are utilized in translational breast cancer research; 3. At the end of this session, participants will be able to describe how newly identified target molecules can potentially be utilized in breast cancer management in the future. |
| 2:30 | Oral Presentation 5 - Impact of macrophages on immune checkpoint inhibitor response in DNA mismatch repair-deficient neuroblastoma tumours - Megan Hong, PhD Candidate |
| 2:40 | Oral Presentation 6 - DNA methylation profiles define new epigenetic-based pancreatic ductal adenocarninoma subtypes - Joana Ribeiro Pinto, PhD. Candidate |
| 2:50 | Oral Presentation 7 - Analyzing the effect of neoadjuvant stereotactic ablative radiotherapy (SABR) on pancreatic tumour perfusion using computed tomography perfusion (CTP) - Jin-Young Bang, MSc. Candidate |
| 3:00 | Oral Presentation 8 - Exploring Principles of the Interplay Between Tumour-Initiating Cells and the Tumour Microenvironment in Glioblastoma - Alan Cieslukowski, MSc. Candidate |
| 3:10 - 4:45 | AFTERNOON POSTER AND NETWORKING SESSION (Even Numbers) Regency Conference Room AND Chelsea Meeting Room & Atrium |
| 3:10 | Poster Viewing and Judging (Even Numbers) Please enjoy refreshments and a light snack while viewing the scientific poster presentations. |
| 4:45 - 5:30 | AWARD CEREMONY, CONCLUDING REMARKS AND NETWORKING Crystal Ballroom |
| 4:45 | Presentation of Awards Michael Ott, Morgan Black, Vanessa Dumeaux, Ana Lohmann Department of Oncology, Excellence in Academic and Teaching Awards (5) Denise Power Cancer Research Staff Award of Excellence (1) Oral (2) and Poster Presentation Awards (10) |
| 5:25 | Concluding Remarks and Adjournment Vanessa Dumeaux and Ana Lohmann |
| *25% of this program is dedicated to participant interaction.
* This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by Continuing Professional Development, Schulich School of Medicine & Dentistry, Western University. You may claim a maximum of 3.75 hours (credits are automatically calculated). *This program has received an educational grant or in-kind support from; Silver Sponsors: AbbVie, Agendia, AstraZeneca, Astella, Eisai, EMD Sereno, GSK, Ipsen, Janssen, Jazz Pharmaceuticals, Knight Therapeutics, Lilly, Merck, Novartis, Pfizer, Roche. Bronze Sponsors:BeiGene, Gilead, Takeda |
#LNDONTONCOLOGY #ONCRESEARCHDAY
